Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors

by Bedard, P.L, Brohl, A.S, Cunningham, R., Giobbie-Hurder, A., Hathaway, E., Manos, M., Rahma, O.E, Renouf, D.J, Rodig, S., Severgnini, M., Sharon, E., Stephen Hodi, F., Streicher, H., Tyan, K.
Published 2022

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

by Butterfield, L.H, Conejo-Garcia, J.R, El Naqa, I.M, Hwu, P., Karunamurthy, A.D, Kirkwood, J.M, Laframboise, W.A, Lee, S.J, Sondak, V.K, Stephen Hodi, F., Storkus, W.J, Streicher, H., Tan, A.-C, Tarhini, A.A
Published 2022